Skip to main content
. Author manuscript; available in PMC: 2022 Mar 4.
Published in final edited form as: Brain Behav Immun. 2020 Feb 22;87:610–633. doi: 10.1016/j.bbi.2020.02.006

Table. 1:

Primary and secondary antibodies utilized in the current study.

1° Antibody Species Dilution Manufacturer Product #

COX-2 Goat (Gt) 1: 1000 Abcam ab23672
GFAP Chicken (Ch) 1 : 1000 Abcam ab4674
lba-1 Rabbit (Rb) 1 : 1000 Wako 019-19741
IL-1 1β/Pro-IL-1β Rb 1 : 500 Abcam ab9722
IL-6 Gt 1 : 500 R&D AF506
MAP-2 Rb 1 : 5000 Abcam ab32454
NeuN Alexa® Fluor 647 Rb 1 : 1000 Abcam ab190565
TNF-α Gt 1 : 2000 R&D AF-510-NA
VGIuT2 Guinea Pig (GP) 1 : 2000 Millipore AB2251-I

2° Antibody Species Dilution Manufacturer Product #

Anti-Ch Alexa® Fluor 488 Donkey (Dk) 1 : 1000 Jackson ImmunoResearch (JIR) 703-545-155
Anti-Gt Alexa® Fluor 647 Dk 1: 1000 JIR 705-295-003
Anti-Gt Biotinylated Bt Dk 1 : 5000 JIR 705-065-003
Anti-GPTRITC Dk 1 : 1000 JIR 706-545-148
Anti-Rb Alexa® Fluor 488 Dk 1 : 1000 JIR 711-475-152
Anti-Rb Alexa® Fluor 647 Dk 1 : 1000 JIR 711-295-152
Anti-Rb Bt Dk 1 : 5000 JIR 711-065-152

Abbreviations are as follows: Cyclooxygenase-2 (COX-2); Glial fibrillary acidic protein (GFAP); Ionized calcium-binding adapter molecule (lba-1); lnterleukin-1 beta (IL-1β); lnterleukin-6 (IL-6); Microtubule associated protein 2 (MAP2); Neuronal Nuclei (NeuN);Tumor necrosis factor-alpha (TNF-α); vesicular glutamate transporter 2 (VGIuT2).